IRIS has a Million Reasons to Celebrate! ?? We are overjoyed to share our incredible milestone: IRIS has completed ONE MILLION diabetic retinal exams! This remarkable achievement is a testament to the unwavering dedication of our extraordinary clients, partners, and the IRIS team. Together, we have tirelessly worked toward our shared mission of ending preventable blindness. Join us in celebrating this monumental milestone and spreading the joy! Together, we are transforming lives and bringing hope to millions affected by diabetes. Thank you for being a part of this incredible journey!
Intelligent Retinal Imaging Systems - IRIS
医院和医疗保健
Pensacola，Florida 2,907 位关注者
Retinal imaging software that makes it easy for care providers to improve quality, clinical, and financial performance.
关于我们
Intelligent Retinal Imaging Systems (IRIS) is the leading teleretinal solution provider in the U.S. We are on a mission to end preventable blindness by making it easy for our partners to provide point-of-care diabetic eye exams. Our camera-agnostic solution is built to go where your patients are, helping you close one of the most challenging care gaps for people with diabetes. We drastically increase access to preventative eye care for underserved populations to help our clients elevate HEDIS and Star ratings and improve their clinical, quality, and financial performance. IRIS software can be utilized with a variety of fundus cameras ranging in price and portability. We integrate with any EMR, facilitating a seamless workflow from order creation to results delivery, and we have a quick, straightforward implementation process. Our experts will guide you as you select a camera and customize a workflow tailored to your needs. From staff training to exam interpretation to ongoing program support, we provide everything you need to deploy your program as quickly and seamlessly as possible. Your long-term success is our priority. We empower our clients to achieve their objectives with continuous education, real-time data analytics, and dedicated support. IRIS is with you every step of the way to ensure you have everything you need to reach your goals. IRIS was founded in 2011 by nationally recognized retina surgeon Dr. Sunil Gupta, who wanted to address the problem of patients with diabetes seeking treatment when it was already too late to save their vision. IRIS is the solution to that problem: A company committed to ending preventable blindness in the U.S. using top-quality, cloud-based technology. IRIS has received the 2020 Microsoft AI for Health Award, the 2017 Microsoft Innovation Award, and the 2016 Frost & Sullivan New Product Innovation Award in Diabetic Retinopathy. For additional information, please visit www.retinalscreenings.com.
- 网站
-
https://www.retinalscreenings.com
Intelligent Retinal Imaging Systems - IRIS的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 11-50 人
- 总部
- Pensacola，Florida
- 类型
- 私人持股
- 创立
- 2011
- 领域
- Diabetic Retinopathy、Retinal Exams、Diabetic Care、Telemedicine、Cloud-Based Software、Artificial Intelligence、AI、Diabetic Eye Exams、Diabetic Eye Disease、Healthcare Technology、Healthcare Software、Retinal Imaging、Ophthalmology、Healthcare IT、Healthcare Innovation、Population Health、HEDIS、Star、Medicare、Healthcare Access和Closing Care Gaps
产品
地点
-
主要
获取路线
2 N Palafox Street, Suite 200
US，Florida，Pensacola，32502
Intelligent Retinal Imaging Systems - IRIS员工
-
Matt Rice
Healthcare Growth Equity Investor
-
Thomas Foster
Seeking an end to preventable blindness
-
Casey Jones, MHA
Customer Service + Patient Experience + Strategic Planning + Process Improvement + Goal Setting + Leadership Development + Community Engagement
-
Jamo Rubin, MD
CEO, RightSite Health
动态
-
We’re heading to American Medical Group Association (AMGA)’s 2025 Annual Conference this week — come say hello! Diabetic retinopathy is the leading cause of blindness in working age adults, but less than 50% of at-risk patients received their annual diabetic eye exam. With over 1.5M exams performed, IRIS has the expertise to help you close this crucial gap. Stop by booth 506 to see how our seamless, point-of-care solution can help you improve patient outcomes while elevating clinical, quality, and financial performance. Ready to transform patient care? Let's chat about it! #AC2025
-
-
Diabetic retinopathy is the leading cause of blindness in working-age adults in the United States, but it's largely preventable with early detection. Too often, patients miss their annual diabetic eye exam due to access barriers, putting their sight at risk. IRIS helps our clients bring this crucial exam to the point of care with ease — helping close care gaps, boost quality metrics, and prevent vision loss before it's too late. Let's make preventable blindness a thing of the past! Schedule a demo today: https://lnkd.in/ebYpx5m #DiabeticRetinopathy #DiabetesCare #HealthcareTechnology #EndPreventableBlindness https://lnkd.in/eh8cZcKc
-
RISE kicks off tomorrow... let’s connect! ?? We’re ready to help you transform care delivery, close care gaps, and boost ratings ?? Swing by booth 425 to see how IRIS helps you make diabetic eye exams more accessible — because preventing blindness starts with early detection. We can't wait to see you there! ?? #RISENational2025 #MedicareAdvantage #HEDIS #StarRatings #DiabeticEyeExams
-
A five-minute exam could save a lifetime of sight ??? With 537 million people living with diabetes worldwide, the risk of diabetic retinopathy — the leading cause of blindness in working-age adults — is higher than ever. Unfortunately, many at-risk patients lack access to eye exams, delaying diagnoses until it’s too late. That’s where point-of-care teleretinal imaging comes in. With a fast, non-invasive screening that delivers quick results, providers can close care gaps and prevent avoidable blindness in their patients. Learn how IRIS is transforming diabetic eye care and making sight-saving exams more accessible than ever. ?? Read more: https://lnkd.in/eAj9zQqm ?? Request a demo: https://lnkd.in/ebYpx5m
-
?? Heading to RISE next week? Let’s connect! IRIS is the leading teleretinal provider in the U.S. with 1M+ diabetic eye exams conducted — and we’re ready to help you close this critical care gap for at-risk patients. Stop by booth 425 to see how our seamless, point-of-care solution can boost clinical outcomes, quality scores, and financial performance. Let’s talk about how we can make an impact together. See you there! ????? #RISENational2025 #MedicareAdvantage #HEDIS #StarRatings #DiabetesCare #DiabeticRetinopathy
-
-
Did you know? Less than 50% of people who have diabetes receive their annual diabetic eye exam. However, diabetic retinopathy usually doesn't show symptoms in the early stages, leaving many people unaware that they have eye disease. With IRIS, you can quickly and easily provide these exams at point of care to minimize missed exams while closing care gaps and elevating compliance rates. Ready to learn more about how IRIS can help you increase access to this crucial exam? Contact us today! ?? https://lnkd.in/ebYpx5m
-
-
?? Comprehensive eye care goes beyond just vision screenings — it’s about catching eye diseases before it’s too late. With IRIS, you can close the gap in diabetic eye exams, ensuring at-risk patients get the care they need when it matters most. Read the full guide below to see how IRIS can help you elevate patient care and save sight! ?? ?? Read more: https://lnkd.in/en_gP9a5 ?? Request a demo: https://lnkd.in/ebYpx5m #SavingSightWithIRIS #PreventBlindness #DiabeticEyeCare #HealthcareInnovation
-
?? We're live at NACHC! Stop by booth 114 to see how IRIS can help you bring diabetic eye exams to the point of care —meeting quality measures, enhancing patient care, and improving outcomes. As the leading teleretinal solution provider in the U.S., we make closing the care gap simple, seamless, and efficient ? Let’s transform patient care together! Come chat with us or reach out today ?? https://lnkd.in/ebYpx5m
-